Tekmira Abandons Ebola Drug Development, Changing Focus To Hepatitis B Cure

The Canadian Press, 20 Jul, 2015 10:56 AM

TORONTO — One month after clinical trials for a once-promising Ebola drug were suspended, the company behind the treatment has suspended all research on the compound.

Tekmira Pharmaceuticals says it has stopped all work on its TKM-Ebola drug and is re-evaluating the contract it signed with the U.S. Department of Defense to develop it.

In a news release, Tekmira says it's changing its name to Arbutus Biopharma Corp. to reflect its new focus on developing a cure for chronic hepatitis B.

Clinical trials for the TKM-Ebola drug in Sierra Leone were suspended in June after an interim assessment of the project concluded the drug wasn't showing beneficial results.

The statement Monday offered no comment on the future of a sister drug the company was developing that was designed to fight Marburg fever, which is similar to Ebola.

Prev Next

MORE National ARTICLES

Bylaw Officer Struck With Skateboard At Memorial Arena Treated In Kamloops Hospital

RCMP Cpl. Cheryl Bush says the female officer approached a man who was spray painting on the back of Memorial Arena at about 8:30 p.m. on Sunday while a junior lacrosse game was winding down inside.

Bylaw Officer Struck With Skateboard At Memorial Arena Treated In Kamloops Hospital

Expanding Tax-Free-Savings Limit Offers Little For Lower, Middle Earners: Study

OTTAWA — The Harper government's recent move to raise the contribution ceiling on tax-free savings accounts offers little to benefit low- and middle-income Canadians, a new analysis of federal tax data has found.

Expanding Tax-Free-Savings Limit Offers Little For Lower, Middle Earners: Study

Porter Airlines Fined $150,000 For Sending Emails Without An Unsubscribe Button

The CRTC says the Toronto-based airline has agreed to pay a $150,000 fine for sending emails without an unsubscribe button or one that was clearly labelled.

Porter Airlines Fined $150,000 For Sending Emails Without An Unsubscribe Button

Heavy Use Of Antibiotics In Nursing Homes Equates To Risk For Residents: Study

TORONTO — A study of antibiotic use in Ontario nursing homes shows huge variation in the amounts of the drugs residents receive.

Heavy Use Of Antibiotics In Nursing Homes Equates To Risk For Residents: Study

Dalhousie Task Force Calls For Overhaul Of Complaint System

HALIFAX — A task force that looked into Dalhousie University's response to dentistry students who posted misogynistic comments on Facebook is calling on the school to overhaul the way it handles complaints of sexism and inequality.